Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance

Zou X, Xu Q, You R, Yin G

Journal of Hepatocellular Carcinoma 2023, 10:267-279

Published Date: 16 February 2023